| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.27 | 0.4 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |